TL;DR
During the initial COVID-19 outbreak in Wuhan, ICU beds were a critically scarce resource. This study utilizes machine learning to identify patients who clinically required intensive care but did not receive it. The findings reveal a "Missing-ICU (MI)-mortality" rate of 41%, compared to a 32% mortality rate for those admitted to the ICU—quantifying the lives that could have been saved with adequate resources.
The Challenge: Quantifying the "Missing-ICU" Gap
In the early stages of a pandemic, medical systems often face a "sudden turnover" where patients' conditions deteriorate rapidly, overwhelming Intensive Care Units (ICUs). When demand exceeds supply, clinicians are forced to make difficult triage decisions.
While the mortality rate of patients in the ICU is often reported, the mortality of those who should have been there but weren't due to bed shortages is rarely quantified. By defining and estimating "Missing-ICU (MI)-mortality," this research provides a data-driven argument for the efficacy of ICU intervention and offers a tool for better resource planning in future health crises.
Methodology: Prognostic Modeling via Ensemble Learning
The researchers conducted a retrospective study using data from 733 patients. To identify who "needed" an ICU, they developed a prognostic classification model through the following steps:
- Feature Selection: Analysis of 909 clinical factors (demographics, lab results, and symptoms) identified the top 10 features with the highest Area Under the Curve (AUC) to build a streamlined, high-performance model.
- Handling Class Imbalance: Only 25 of the 733 patients were admitted to the ICU. To address this imbalance, the authors employed ensemble learning with balanced sampling, training 29 different Support Vector Machine (SVM) classifiers on balanced subsets and using a majority voting system for final predictions.
- Defining MI-Mortality: The model identifies patients predicted to need ICU care. By analyzing the subset of these patients who died without receiving ICU care, the authors calculated the MI-mortality.
Dataset and Clinical Indicators
The study utilized a dataset of 733 in-patients diagnosed with COVID-19 at the Huangpi Hospital of Traditional Chinese Medicine in Wuhan, China (January–March 2020).
- Features: 909 total features, including 858 continuous variables (e.g., lab values) and 51 categorical variables (e.g., comorbidities).
- Key Biomarkers: High levels of hs-cTnI (High sensitivity troponin I) and Myoglobin (Mb)—markers of cardiac stress—were the most significant predictors of clinical deterioration.
Key Results: The 9% Survival Advantage
The prognostic model demonstrated high reliability in identifying critical patients, achieving a predictive accuracy of 0.8288 and an AUC of 0.9119 when utilizing the top 10 clinical features.
Quantifying the Impact of ICU Care: * MI-mortality (Predicted need, no ICU): 41% * ICU-mortality (Actual ICU care): 32%
This 9% survival gap suggests that ICU intervention significantly reduces the risk of death for critical patients, even in high-stress environments. Furthermore, the model could make these predictions using data collected 1–15 days before actual ICU admission, providing a vital early warning window for hospital administrators.
Discussion and Limitations
While the study provides a compelling quantification of "savable lives," the authors acknowledge several limitations. The data is from a single center in Wuhan with a small positive sample size (25 ICU patients), which may affect the model's generalizability. Future work should incorporate cross-institutional samples to validate these findings and refine the early warning system for broader clinical application.
Summary updated